Effects of naltrexone on amphetamine-induced locomotion and rearing: Acute and repeated injections

Psychopharmacology

Volumn 131, Issue 3, 1997, Pages 230-238

  Balcells Olivero, Mercedes ^a   Vezina, Paul ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Amphetamine; Locomotion; Naltrexone; Opiate dopamine interactions; Opioids; Psychomotor stimulants; Rearing; Sensitization

Indexed keywords

AMPHETAMINE; DOPAMINE; NALTREXONE; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABUSE; DRUG EXPOSURE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RAT; REARING; SENSITIZATION;

AMPHETAMINE; ANIMALS; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030875020     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050288     Document Type: Article

References (68)

1. Andrews JS, Holtzman SG (1987) Effects of naloxone and diprenorphine on amphetamine-stimulated behavior in guinea pigs and rats. Neuropharmacology 26: 1115-1120
2. Badiani A. Leone P, Stewart J (1995) Intra-VTA injections of the mu-opioid antagonist CTOP enhance locomotor activity. Brain Res 690: 112-116
3. Cador M, Bjijou Y, Stinus L (1995) Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65: 385-395
4. Chesselet MF, Cheramy A, Reisine TD, Lubetzki C, Glowinski J, Fournie-Zaluski MC, Roques B (1982) Effects of various opiates including specific δ and μ agonists on dopamine release from nigrostriatal dopaminergic neurons in vitro in the rat and in vivo in the cat. Life Sci 31: 2291-2294
5. 1 and δ opioid receptors. Psychopharmacology 120: 347-355
6. Cooper DMF, Londos C, Gill DL, Rodbell M (1986) Opiate-receptor-mediated inhibition of adenylate cyclase in rat striatal plasma membranes. J Neurochem 38: 1164-1167
7. Corrigall WA, Coen KM (1991) Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology 104: 167-170
8. Cunningham ST, Kelley AE (1992a) Opiate infusion into nucleus accumbens: contrasting effects on motor activity and responding for conditioned control. Brain Res 588: 104-114
9. Cunningham ST, Kelley AE (1992b) Evidence for opiate-dopamine cross-sensitization in nucleus accumbens: studies of conditioned reward. Brain Res Bull 29: 675-680
10. Dettmar PW, Cowan A, Walter DS (1978) Naloxone antagonizes behavioural effects of d-amphetamine in mice and rats. Neuropharmacology 17:1041-1044
11. Devine DP, Leone P, Pocock D, Wise RA (1993a) Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther 266: 1236-1246
12. Devine DP, Leone P, Wise RA (1993b) Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists. Eur J Pharmacol 243: 55-64
13. De Vries TJ, Babovic-Vuksanovic D, Elmer G, Shippenberg TS (1995) Lack of involvement of δ-opioid receptors in mediating the rewarding effects of cocaine. Psychopharmacology 120: 442-448
14. 125I-DPDPE). Synapse 6: 121-132
15. Finley JCW, Maderdrut JL, Petrusz P (1981) The immunocytochemical localization of enkephalin in the central nervous system of the rat. J Comp Neurol 198: 541-565
16. Franklin KBJ, Robertson A (1982) Effects and interactions of naloxone and amphetamine on self-stimulation of the prefrontal cortex and dorsal tegmentum. Pharmacol Biochem Behav 16: 433-436
17. Gentleman S, Parenti M, Neff NH, Pert CB (1983) Inhibition of dopamine-activated adenylate cyclase and dopamine binding by opiate receptors in rat striatum. Cell Mol Neurobiol 3: 17-26
18. Gerrits MAFM, Putkina N, Zvartau EE, van Ree JM (1995) Opioid blockade attenuates acquisition and expression of cocaine-induced place preference conditioning in rats. Psychopharmacology 119: 92-98
19. Haber S, Hatsukami T, Berger PA, Barchas JD, Akil H (1978) Naloxone blocks amphetamine-induced rearing: potential interaction between catecholamines and endorphins. Prog Neuro-Psychopharmacol 2: 425-430
20. Hahn EF (1990) Opiate antagonists and anti-HIV agents. In: Pham PTK, Rice K (eds) Drugs of abuse: chemistry, pharmacology, immunology and AIDS. NIDA Res Monogr 96: 80-99
21. Harris RA, Snell D (1980) Interactions between naltrexone and non-opiate drugs evaluated by schedule-controlled behavior. Neuropharmacology 19: 1087-1093
22. Harris RA, Snell D, Loh HH, Way EL (1977) Behavioral interactions between naloxone and dopamine agonists. Eur J Pharmacol 43: 243-246
23. Heidbreder C, Goldberg SR, Shippenberg TS (1993) Inhibition of cocaine-induced sensitization by the δ-opioid receptor antagonist naltrindole. Eur J Pharmacol 243: 123-127
24. 1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther 258: 882-890
25. Hitzemann R, Curell J, Hom D, Loh H (1982) Effects of naloxone on d-amphetamine- and apomorphine-induced behavior. Neuropharmacology 21: 1005-1011
26. Holtzman SG (1974) Behavioral effects of separate and combined administration of naloxone and d-amphetamine. J Pharmacol Exp Ther 189: 51-60
27. Hooks MS, Jones DN, Justice JB Jr, Holtzman SG (1992) Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens. Pharmacol Biochem Behav 42: 765-770
28. Itoh T, Murai S, Yoshida H, Masuda Y, Saito H, Chen CH (1987) Effects of methamphetamine and morphine on the vertical and horizontal motor activities of mice. Pharmacol Biochem Behav 27: 193-197
29. Johnson K, Churchill L, Klitenisck MA, Hooks MS, Kalivas PW (1996) Involvement of the ventral tegmental area in locomotion elicited from the nucleus accumbens or ventral pallidum. J Pharmacol Exp Ther 277: 1122-1131
30. Jones DNC, Bowen WD, Portoghese PS, Holtzman SG (1993) δ-Opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine. Eur J Pharmacol 249: 167-177
31. Jones DNC, Holtzman SG (1992a) Effects of naloxone infusion upon spontaneous and amphetamine-induced activity. Eur J Pharmacol 221: 161-165
32. Jones DN, Holtzman SG (1992b) Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors. J Pharmacol Exp Ther 262: 638-645 x5760
33. Kalivas PW, Duffy P (1993) Time course of extracellular dopamine and behavioral sensitization to cocaine: I. Dopamine axon terminals. J Neurosci 13: 266-275
34. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16: 223-244
35. Kalivas PW, Weber B (1988) Amphetamine injected into the AlO dopamine region sensitizes rats to peripheral amphetamine and cocaine. J Pharmacol Exp Ther 245: 1095-1102
36. Kalivas PW, Duffy P, DuMars LA, Skinner C (1988) Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J Pharmacol Exp Ther 245: 485-492
37. Khachaturian H, Lewis ME, Watson SJ (1983) Enkephalin systems in diencephalon and brainstem of the rat. J Comp Neurol 220: 310-320
38. Kirk RE (1968) Experimental design: procedures for the behavioral sciences. Brooks/Cole, Belmont
39. Kuczenski R (1983) Biochemical actions of amphetamine and other stimulants. In: Creese I (ed) Stimulants: neurochemical, behavioral and clinical perspectives. Raven Press, New York, pp 31-61
40. Kuczenski R, Segal DS (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 9: 2051-2065
41. LeMoine C, Normand E, Guitteny AF, Fouque B, Teoule R, Bloch B (1990) Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc Natl Acad Sci USA 87: 230-234
42. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1987) Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neuro-sci 7:2445-2464
43. Marley RJ, Shimosato K, Gewiss M, Thorndike E, Goldberg SR. Schindler CW (1995) Long-term sensitization to the behavioral effects of naltrexone is associated with regionally specificchanges in the number of μ and δ opioid receptors in rat brain. Life Sci 56: 767-774
44. Mazurski EJ, Beninger RJ (1987) Environment-specific conditioning and sensitization with (+)-amphetamine. Pharmacol Biochem Behav 27: 61-65
45. Michael-Titus A, Dourmap N, Costentin J (1989) Mu and delta opioid receptors control differently the horizontal and vertical components of locomotor activity in mice. Neuropeptides 13: 235-242
46. Mickley AG, Mulvihill MA, Postler MA (1990) Brain μ and δ opioid receptors mediate different locomotor hyperactivity responses of the C57BL/6J mouse. Psychopharmacology 101: 332-337
47. 14C]naloxone in the rat and some comparative observations on nalorphine. J Pharmacol Exp Ther 196: 257-268
48. 2-opioid agonists in rat caudate putamen. J Neurochem 65: 125-133
49. Paulson PE, Robinson TE (1995) Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19: 56-65
50. Perugini M, Vezina P (1994) Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther 270: 690-696
51. Pierce RC, Bell K, Duffy P, Kalivas PW (1996) Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 16: 1550-1560
52. Reid LD, Glick SD, Menkens KA, French ED, Bilsky EJ, Porreca F (1995) Cocaine self-administration and naltrindole, a delta-selective opioid antagonist. Neuroreport 6: 1281-1284
53. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11: 157-198
54. Schad CA, Justice JB Jr, Holtzman SG (1995) Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine. Eur J Pharmacol 275: 9-16
55. Schindler CW, Goldberg SR, Katz JL (1993) Pharmacological specificity of enhanced sensitivity to naltrexone in rats. Psychopharmacology 110: 60-68
56. Segal DS, Kuczenski R (1992) In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res 571: 330-337
57. Shippenberg TS, Heidbreder C (1995) The δ-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. Eur J Pharmacol 280: 55-61
58. Spanagel R, Herz A, Shippenberg TS (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89: 2046-2050
59. Stinus L, Winnock M, Kelley AE (1985) Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioral supersensitivity to opiates. Psychopharmacology 85: 323-328
60. Swerdlow NR, Vaccarino FJ, Koob GF (1985) Effects of naloxone on heroin-, amphetamine- and caffeine-stimulated locomotor activity in the rat. Pharmacol Biochem Behav 23: 499-501
61. Swerdlow NR, Amalric M, Koob GF (1987) Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus. Pharmacol Biochem Behav 26:765-769
62. Trovero F, Herve D, Desban M, Glowinski J, Tassin JP (1990) Striatal opiate μ-receptors are not located on dopamine nerve endings in the rat. Neuroscience 39: 313-321
63. Trujillo KA, Belluzzi JD, Stein L (1991) Naloxone blockade of amphetamine place preference conditioning. Psychopharmacology 104: 265-274
64. Vezina P (1993) Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res 605: 332-337
65. 1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J Neurosci 16: 2411-2420
66. Winslow JT, Miczek KA (1988) Naltrexone blocks amphetamine-induced hyperactivity, but not disruption of social and agonistic behavior in mice and squirrel monkeys. Psychopharmacology 96: 493-499
67. Wolf ME, White FJ, Hu XT (1994) MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci 14: 1735-1745
68. Zimmerman DM, Leander JD (1990) Opioid antagonists: structure activity relationships. In: Pham PTK, Rice K (eds) Drugs of abuse: chemistry, pharmacology, immunology, and AIDS. NIDA Res Monogr 96: 50-60